F-star Therapeutics, Inc. Debt to Equity Ratio 2016-2022 | FSTX
Current and historical debt to equity ratio values for F-star Therapeutics, Inc. (FSTX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. F-star Therapeutics, Inc. debt/equity for the three months ending September 30, 2022 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2022-09-30 | $0.03B | $0.06B | 0.47 |
| 2022-06-30 | $0.03B | $0.07B | 0.41 |
| 2022-03-31 | $0.03B | $0.09B | 0.30 |
| 2021-12-31 | $0.03B | $0.10B | 0.27 |
| 2021-09-30 | $0.03B | $0.09B | 0.27 |
| 2021-06-30 | $0.03B | $0.10B | 0.26 |
| 2021-03-31 | $0.02B | $0.04B | 0.53 |
| 2020-12-31 | $0.02B | $0.04B | 0.48 |
| 2020-09-30 | $0.01B | $0.02B | 0.49 |
| 2020-06-30 | $0.01B | $0.02B | 0.34 |
| 2020-03-31 | $0.03B | $0.03B | 0.96 |
| 2019-12-31 | $0.03B | $0.01B | 3.51 |
| 2019-09-30 | $0.03B | $0.04B | 0.66 |
| 2019-06-30 | $0.01B | $0.05B | 0.19 |
| 2019-03-31 | $0.01B | $0.05B | 0.25 |
| 2018-12-31 | $0.01B | $0.06B | 0.23 |
| 2018-09-30 | $0.02B | $0.06B | 0.24 |
| 2018-06-30 | $0.01B | $0.03B | 0.40 |
| 2018-03-31 | $0.02B | $0.03B | 0.47 |
| 2017-12-31 | $0.02B | $0.04B | 0.51 |
| 2017-09-30 | $0.02B | $0.03B | 0.69 |
| 2017-06-30 | $0.02B | $0.04B | 0.37 |
| 2017-03-31 | $0.01B | $0.01B | 1.02 |
| 2016-12-31 | $0.01B | $0.02B | 0.58 |
| 2016-09-30 | $0.00B | $0.01B | 0.27 |
| 2016-06-30 | $0.00B | $0.02B | 0.23 |
| 2016-03-31 | $0.00B | $0.01B | 0.42 |
| 2015-12-31 | $0.00B | $0.01B | 0.32 |
| 2015-09-30 | $0.00B | 0.00 | |
| 2015-06-30 | $0.00B | 0.00 | |
| 2015-03-31 | $0.00B | 0.00 | |
